Loading clinical trials...
Loading clinical trials...
To evaluate the therapeutic effectiveness of H. pylori eradication in stage IE \& IIE-1 primary low-grade B cell lymphoma of MALT of the stomach
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Health Research Institutes, Taiwan
NCT06228963 · MALT Lymphoma of Stomach, Helicobacter Pylori Infection
NCT01808599 · MALT Lymphoma
NCT07376330 · MALT Lymphoma
NCT00783367 · Follicular Lymphoma, Marginal Zone B-Cell Lymphoma, and more
NCT05003141 · Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, and more
National Taiwan University Hospital
Taipei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions